Metropolitan Life Insurance Company (MetLife)’s Pfizer PFE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-227,738	Closed	-$6.32M	–	1536
2024 Q1	$6.32M	Sell	227,738 -2,098	-0.9%	-$58.2K	0.28%	61
2023 Q4	$6.62M	Sell	229,836 -3,763	-2%	-$114K	0.31%	52
2023 Q3	$7.75M	Sell	233,599 -12,421	-5%	-$439K	0.4%	40
2023 Q2	$9.02M	Sell	246,020 -5,053	-2%	-$197K	0.44%	36
2023 Q1	$10.2M	Sell	251,073 -60,418	-19%	-$2.61M	0.53%	30
2022 Q4	$16M	Sell	311,491 -16,237	-5%	-$778K	0.71%	24
2022 Q3	$14.3M	Sell	327,728 -3,851	-1%	-$187K	0.68%	23
2022 Q2	$17.4M	Sell	331,579 -8,437	-2%	-$430K	0.76%	20
2022 Q1	$17.6M	Sell	340,016 -294,729	-46%	-$15.3M	0.63%	24
2021 Q4	$37.5M	Sell	634,745 -24,338	-4%	-$1.21M	0.51%	25
2021 Q3	$28.3M	Sell	659,083 -21,463	-3%	-$951K	0.41%	39
2021 Q2	$26.7M	Sell	680,546 -8,252	-1%	-$321K	0.38%	43
2021 Q1	$25M	Sell	688,798 -31,853	-4%	-$1.13M	0.37%	48
2020 Q4	$26.5M	Sell	720,651 -79,152	-10%	-$2.9M	0.4%	42
2020 Q3	$27.8M	Sell	799,803 -35,069	-4%	-$1.23M	0.47%	35
2020 Q2	$25.9M	Sell	834,872 -48,556	-5%	-$1.65M	0.46%	37
2020 Q1	$27.4M	Sell	883,428 -3,372	-0.4%	-$115K	0.56%	26
2019 Q4	$33M	Buy	886,800 +19,142	+2%	+$682K	0.53%	30
2019 Q3	$29.6M	Sell	867,658 -4,424	-0.5%	-$161K	0.5%	32
2019 Q2	$35.8M	Buy	872,082 +68,852	+9%	+$2.73M	0.6%	23
2019 Q1	$32.4M	Sell	803,230 -65,811	-8%	-$2.64M	0.59%	26
2018 Q4	$36M	Sell	869,041 -22,581	-3%	-$937K	0.72%	16
2018 Q3	$37.3M	Sell	891,622 -32,061	-3%	-$1.23M	0.63%	20
2018 Q2	$31.8M	Sell	923,683 -45,020	-5%	-$1.54M	0.52%	31
2018 Q1	$32.6M	Buy	968,703 +4,820	+0.5%	+$166K	0.46%	26
2017 Q4	$33.1M	Sell	963,883 -2,010,498	-68%	-$68.6M	0.44%	29
2017 Q3	$101M	Sell	2,974,381 -55,027	-2%	-$1.77M	0.63%	21
2017 Q2	$96.5M	Sell	3,029,408 -94,751	-3%	-$2.99M	0.67%	20
2017 Q1	$101M	Sell	3,124,159 -105,245	-3%	-$3.32M	0.7%	21
2016 Q4	$99.5M	Sell	3,229,404 -80,806	-2%	-$2.47M	0.72%	21
2016 Q3	$106M	Sell	3,310,210 -24,592	-0.7%	-$822K	0.78%	18
2016 Q2	$111M	Sell	3,334,802 -8,464	-0.3%	-$270K	0.83%	18
2016 Q1	$94M	Sell	3,343,266 -125,693	-4%	-$3.59M	0.72%	22
2015 Q4	$106M	Sell	3,468,959 -89,097	-3%	-$2.8M	0.82%	18
2015 Q3	$106M	Sell	3,558,056 -59,192	-2%	-$1.9M	0.76%	19
2015 Q2	$115M	Sell	3,617,248 -20,646	-0.6%	-$673K	0.81%	13
2015 Q1	$120M	Sell	3,637,894 -144,649	-4%	-$4.6M	0.88%	13
2014 Q4	$112M	Sell	3,782,543 -3,339	-0.1%	-$95.7K	0.77%	15
2014 Q3	$106M	Sell	3,785,882 -77,274	-2%	-$2.17M	0.76%	16
2014 Q2	$109M	Sell	3,863,156 -201,059	-5%	-$5.73M	0.76%	15
2014 Q1	$124M	Sell	4,064,215 -124,714	-3%	-$3.72M	0.86%	15
2013 Q4	$122M	Sell	4,188,929 -162,666	-4%	-$4.73M	0.86%	14
2013 Q3	$119M	Sell	4,351,595 -56,405	-1%	-$1.53M	0.91%	14
2013 Q2	$117M	Buy	+4,408,000	New	+$122M	0.93%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PFE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pfizer (PFE) in Q2 2024, closing a stake of 227,738 shares — an estimated $6.32M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $124M in Q1 2014. 2,875 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 227,738 Pfizer shares in Q2 2024, an estimated $6.32M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Pfizer position peaked at $124M in Q1 2014.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.